Genmab News

Genmab News

In accordance with legal requirements, notifications regarding Managers’ Transactions are published in the database of the Danish Financial Supervisory Authority and can be accessed at the following link: https://oasm.dfsa.dk/uk/frontpage.aspx. As a general rule, Genmab no longer issues Company Announcements concerning these transactions.

Date Title View
Jul 04, 2018
Genmab A/S has published its Articles of Association
Jul 03, 2018
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Capital Increase in Genmab as a Result of Employee Warrant Exercise 27.11 KB
Jun 29, 2018
HuMax®-AXL-ADC Progress Triggers Milestone Payment to Seattle Genetics
18_CA_180629_HuMax-AXL-ADC milestone payment.pdf 29.06 KB
Jun 18, 2018
Genmab A/S has published its Articles of Association
Articles of Association dated June 7, 2018 - English 342.27 KB
Jun 07, 2018
Grant of Restricted Stock Units and Warrants to Genmab employees
Grant of Restricted Stock Units and Warrants to Genmab employees 31.31 KB
May 29, 2018
Genmab to Present at the Goldman Sachs 39th Annual Global Healthcare Conference
Genmab to Present at the Goldman Sachs 39th Annual Global Healthcare Conference 13.29 KB
May 26, 2018
Genmab Announces that Janssen Will Stop Studies of Daratumumab in Combination with Anti-PD-(L)1
Genmab to Present at the Goldman Sachs 39th Annual Global Healthcare Conference 13.29 KB
May 24, 2018
Genmab Announces Topline Results in Phase III study of Arzerra® in Indolent Non-Hodgkin’s Lymphoma
Genmab Announces Topline Results in Phase III study of Arzerra® in Indolent Non- Hodgkin's Lymphoma 15.87 KB
May 17, 2018
Genmab Announces Abstracts to be Presented at 23rd EHA Annual Congress
Genmab Announces Abstracts to be Presented at 23rd EHA Annual Congress 63.59 KB
May 16, 2018
Genmab A/S has published its Articles of Association
Genmab A/S has published its Articles of Association 341.3 KB
May 15, 2018
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Capital Increase in Genmab as a Result of Employee Warrant Exercise 14.09 KB
May 08, 2018
Interim Report First Quarter 2018
13_Q1 2018 Interim Report (1).pdf 343.87 KB
May 08, 2018
Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Newly Diagnosed Multiple Myeloma
Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Newly Diagnosed Multiple Myeloma 36.25 KB
Apr 25, 2018
Genmab Announces Data to be Presented at 2018 ASCO Annual Meeting
PDF 73.28 KB
Apr 19, 2018
Genmab A/S has published its Articles of Association
Genmab A/S has published its Articles of Association 341.6 KB
Apr 17, 2018
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2018
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2018.pdf 158.47 KB
Apr 10, 2018
Passing of Genmab A/S' Annual General Meeting
Passing of Genmab A/S' Annual General Meeting 36.84 KB
Apr 10, 2018
Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab
Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab 30.34 KB
Apr 04, 2018
Genmab A/S has published its Articles of Association
Genmab A/S has published its Articles of Association 321.19 KB
Apr 03, 2018
Capital Increase in Genmab as a Result of Employee Warrant Exercise
GEN.OMX_News_2018_4_3_Company_Announcements.pdf 35.91 KB
Mar 08, 2018
Genmab A/S Summons Annual General Meeting
Genmab A/S Summons Annual General Meeting 220.23 KB
Mar 01, 2018
Articles of Association for Genmab A/S
Articles of Association for Genmab A/S 353.19 KB
Feb 28, 2018
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Capital Increase in Genmab as a Result of Employee Warrant Exercise 27.36 KB
Feb 21, 2018
Genmab 2017 Annual Report
Genmab 2017 Annual Report 1.8 MB
Jan 23, 2018
Genmab Announces 2017 Net Sales Figures for DARZALEX® (Daratumumab)
Genmab Announces 2017 Net Sales Figures for DARZALEX® (Daratumumab) 30.79 KB